Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
BriaCell Therapeutics Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/12/2025 | Q2 2025 | N/A | -$0.35 | N/A | N/A | $0 |
| 10/31/2024 | Q1 2025 | N/A | -$0.32 | N/A | N/A | $0 |
| 07/30/2024 | Q4 2024 | N/A | -$0.07 | N/A | N/A | $0 |
| 04/29/2024 | Q3 2024 | N/A | $0.11 | N/A | N/A | $0 |
| 01/30/2024 | Q2 2024 | N/A | -$0.71 | N/A | N/A | $0 |
| 10/30/2023 | Q1 2024 | N/A | $0.38 | N/A | N/A | $0 |
| 07/30/2023 | Q4 2023 | N/A | -$154.27 | N/A | N/A | $0 |
| 04/29/2023 | Q3 2023 | N/A | -$0.28 | N/A | N/A | $0 |
| 01/30/2023 | Q2 2023 | N/A | -$1.73 | N/A | N/A | $0 |
| 10/30/2022 | Q1 2023 | N/A | $0.21 | N/A | N/A | $0 |
| 07/30/2022 | Q4 2022 | N/A | -$1.89 | N/A | N/A | $0 |
| 04/29/2022 | Q3 2022 | N/A | $0.15 | N/A | N/A | $0 |
| 01/30/2022 | Q2 2022 | N/A | $0.71 | N/A | N/A | $0 |
| 10/30/2021 | Q1 2022 | N/A | $0.06 | N/A | N/A | $0 |
| 07/30/2021 | Q4 2021 | N/A | -$0.18 | N/A | N/A | $0 |
| 04/29/2021 | Q3 2021 | N/A | $0.49 | N/A | N/A | $0 |
| 01/30/2021 | Q2 2021 | N/A | $0.03 | N/A | N/A | $0 |
| 10/30/2020 | Q1 2021 | N/A | $0.30 | N/A | N/A | $0 |
| 07/30/2020 | Q4 2020 | N/A | -$0.81 | N/A | N/A | $0 |
| 04/29/2020 | Q3 2020 | N/A | $0.41 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BriaCell Therapeutics Corp. Earnings: FAQ's
BriaCell Therapeutics Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Saturday, April 29th, 2023 based offlast year's report dates.
The conference call for BriaCell Therapeutics Corp.'s latest earnings report can be listened to online.
The conference call transcript for BriaCell Therapeutics Corp.'s latest earnings report can be read online.
BriaCell Therapeutics Corp. (:BCTXW) has a recorded net income of $-20,302,394.BriaCell Therapeutics Corp. has generated $-1.74 earnings per share over the last four quarters.
BriaCell Therapeutics Corp. (:BCTXW) has a price-to-earnings ratio of -6.73 and price/earnings-to-growth ratio is -0.19.